Anavex Life Sciences Corp. (AVXL) Live Share Price, Invest From India

Anavex Life Sciences Corp. Stock Performance

as on January 28, 2026 at 9:37 pm IST

Day's Low
Day's High
$4.89
Day's Price Range
$5.05
$5.00
2.20%
Downside
1.00%
Upside
52 Week's Low
52 Week's High
$2.86
52-Week Price Range
$13.99
$5.00
42.80%
Downside
179.80%
Upside

Anavex Life Sciences Corp. share price movements today

Previous Close: $5.05
Open: $5.05
Volume: 308.3K
Day's Low - High: $4.89 - $5.05
52 Week Low - High: $2.86 - $13.99

Anavex Life Sciences Corp. Historical Returns

1 Month Return: + 38.74 %
3 Month Return: -37.65 %
1 Year Return: -49.04 %
3 Year Return: -52.18 %
5 Year Return: -20.35 %

Anavex Life Sciences Corp. Stock Fundamentals & Key Indicators

Check Anavex Life Sciences Corp. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$451.2M

EPS (TTM)

-0.48

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-43.12%

Anavex Life Sciences Corp. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Anavex Life Sciences Corp. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Anavex Life Sciences Corp.	BUY	$451.2M	-20.35%	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$47.7B	129.26%	1246.03	1.36%
Vertex Pharmaceuticals Incorporated	BUY	$122.3B	106.13%	33.56	31.35%
Beone Medicines Ltd	NA	$37.4B	NA	662.33	1.38%
Regeneron Pharmaceuticals, Inc.	BUY	$80.8B	52.34%	18.28	32.13%

Stock Returns calculator for Anavex Life Sciences Corp. Stock including INR - Dollar returns

The Anavex Life Sciences Corp. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Anavex Life Sciences Corp. investment value today

Current value as on today

₹56,428

Returns

₹43,572

(-43.57%)

Returns from Anavex Life Sciences Corp. Stock

₹49,546 (-49.55%)

Dollar Returns*

₹5,974 (+5.97%)

Analyst Recommendation on Anavex Life Sciences Corp. Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Anavex Life Sciences Corp.. Average target price of $22

Anavex Life Sciences Corp. Share Price Target

Get share price movements and forecasts by analysts on Anavex Life Sciences Corp..

What analysts predicted

77.27%UPSIDE

Target Price

$22

Current Price

Analyzed by

9 Analysts

Target

$22.00

Anavex Life Sciences Corp. target price $22, a slight upside of 77.27% compared to current price of $5. According to 9 analysts rating.

Anavex Life Sciences Corp. Stock’s Investor Sentiment and Interest

Search interest for Anavex Life Sciences Corp. Stock has decreased by -49% in the last 30 days, reflecting a downward trend in search activity.

Time period: December 29, 2025 to January 28, 2026

Change:-49% versus previous 30 day period

Anavex Life Sciences Corp. Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-
Operating Income	-13	-12	-11	-12	-14	-14	-13	-12	-14	-11
EBITDA	1	-10	-9	1	-12	-34	-11	1	-13	-
Interest Expense	1	1	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-11	-10	-9	-10	-12	-11	-12	-11	-13	-9
Income Tax Expense	0	0	0	0	0	0	0	0	0	-
Net Income	-11	-10	-8	-10	-12	-11	-12	-11	-13	-9
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Anavex Life Sciences Corp. Annual Profit & Loss

All numbers in Millions USD

	Sep 2016	Sep 2017	Sep 2018	Sep 2019	Sep 2020	Sep 2021	Sep 2022	Sep 2023	Sep 2024	Sep 2025
Total Revenue	-	-	-	0	-	-	-	-	-	-
Gross Profit	0	-	-	-	-	-	-	-	-	-
Operating Income	-15	-15	-19	-28	-31	-41	-50	-47	-52	-51
EBITDA	-15	-15	-19	-28	-30	-37	-50	-47	5	-
Interest Expense	11	-	0	0	4	4	0	0	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-14	-13	-17	-26	-26	-37	-47	-47	-43	-46
Income Tax Expense	0	0	0	0	0	0	0	0	-2	-
Net Income	-14	-13	-17	-26	-26	-37	-47	-47	-43	-46
Net Profit Margin	0.00%	0.00%	0.00%	3838.69%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Anavex Life Sciences Corp. Quarterly Cash Flow

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Net Income	-10	-8	-10	-12	-11	-12	-11	-13	-9
Operating Cash Flow	-5	-7	-11	-5	-6	-12	-5	-12	-8
Investing Cash Flow	-	-	-	-	-	-	-	-	-
Financing Cash Flow	2	0	7	4	0	0	0	-2	10
Change in Cash	-3	-7	-4	0	-6	-11	-5	-14	1

Anavex Life Sciences Corp. Annual Cash Flow

All numbers in Millions USD

	Sep 2017	Sep 2018	Sep 2019	Sep 2020	Sep 2021	Sep 2022	Sep 2023	Sep 2024	Sep 2025
Net Income	-13	-17	-26	-26	-37	-47	-47	-43	-46
Operating Cash Flow	-9	-12	-18	-21	-30	-24	-27	-30	-39
Investing Cash Flow	-	-	-	-	-	-	-	-	-
Financing Cash Flow	27	8	17	28	153	21	29	11	9
Change in Cash	18	-4	0	7	122	-2	1	-18	-29

Global Institutional Holdings in Anavex Life Sciences Corp.

Funds	Holdings
UBS Group AG	0.55%
Pier Capital, LLC	0.49%
Citadel Advisors Llc	0.38%
Geode Capital Management, LLC	2.35%
Two Sigma Advisers, LLC	0.96%

See all

Insights on Anavex Life Sciences Corp.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 1 month, AVXL stock has moved up by 38.7%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 29.4% return, outperforming this stock by 81.6%
NO EFFECT
Against Peers
In the last 1 year, Beone Medicines Ltd has given 48.3% return, outperforming this stock by 97.3%

About Anavex Life Sciences Corp.

anavex life sciences corp. is a clinical stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodevelopmental and neurodegenerative diseases. anavex is currently in a phase 2a trial for alzheimer's disease (ad) with lead therapeutic, anavex 2-73, an orally available small molecule targeting protein misfolding and cellular stress through activating the sigma-1 receptor. part a topline data of our ongoing phase 2a trial demonstrate a favorable safety, bioavailability, dose-response curve and tolerability/risk profile. anavex 2-73 is a potential platform drug showing encouraging preclinical data rare neurodevelopmental disease: rett syndrome, as well is in epilepsy and multiple sclerosis (ms). in 2015, the company was awarded a research by the michael j. fox foundation (mjff) to study anavex 2-73 for the treatment of parkinson’s disease. headquartered in new york, anavex is an american publicly traded corporation quoted as avxl.

Organisation	Anavex Life Sciences Corp.
Headquarters	630 5th Avenue, New York, NY, United States, 10111
Industry	Health Technology
CEO	Dr. Christopher U. Missling M.B.A., M.S., Ph.D.
E-voting on shares	Click here to vote

Key Management of Anavex Life Sciences Corp.

Name	Title
Dr. Wolfgang Liedtke M.D., Ph.D.	Senior VP & Global Head of Neurology
Dr. Kun Jin Ph.D.	Head of Biostatistics
Ms. Sandra Boenisch CPA, CGA	Principal Financial Officer & Treasurer
Clint Tomlinson	VP of Corporate
Dr. Adebayo Laniyonu Ph.D.	Senior Vice President of Nonclinical Development
Dr. Edward R Hammond M.D., M.P.H., Ph.D.	Chief Medical Officer
Dr. Terrie Kellmeyer Ph.D.	Senior Vice President of Clinical Development
Dr. Juan Carlos Lopez-Talavera M.D., Ph.D.	Senior VP & Head of Research and Development
Dr. Christopher U. Missling M.B.A., M.S., Ph.D.	President, CEO, Secretary & Director

FAQs

What is Anavex Life Sciences Corp. share price today?

Anavex Life Sciences Corp. share price today is $5 as on January 28, 2026 at 9:37 pm IST. Anavex Life Sciences Corp. share today touched a day high of $5.05 and a low of $4.89.

What is the 52 week high and 52 week low for Anavex Life Sciences Corp. share?

Anavex Life Sciences Corp. share touched a 52 week high of $13.99 on July 24, 2025 and a 52 week low of $2.86 on November 14, 2025. Anavex Life Sciences Corp. stock price today i.e. January 28, 2026 at 9:37 pm IST is trending at $5,which is 64.26% down from its 52 week high and 74.83% up from its 52 week low.

What is Anavex Life Sciences Corp.'s market capitalisation today?

Anavex Life Sciences Corp. market capitalisation is $0.00T as on January 28, 2026 at 9:37 pm IST.

How to invest in Anavex Life Sciences Corp. Stock (AVXL) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Anavex Life Sciences Corp. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Anavex Life Sciences Corp. Shares that will get you 0.3000 shares as per Anavex Life Sciences Corp. share price of $5 per share as on January 28, 2026 at 9:37 pm IST.

What is the minimum amount required to buy Anavex Life Sciences Corp. Stock (AVXL) from India?

Indian investors can start investing in Anavex Life Sciences Corp. (AVXL) shares with as little as ₹91.762 or $1 (as of January 28, 2026 at 9:37 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹917.62 in Anavex Life Sciences Corp. stock (as per the Rupee-Dollar exchange rate as on January 28, 2026 at 9:37 pm IST). Based on Anavex Life Sciences Corp. share’s latest price of $5 as on January 28, 2026 at 9:37 pm IST, you will get 2.0000 shares of Anavex Life Sciences Corp.. Learn more about fractional shares .

What are the returns that Anavex Life Sciences Corp. has given to Indian investors in the last 5 years?

Anavex Life Sciences Corp. stock has given -20.35% share price returns and 25.73% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?